(Państwowa Szkoła Wyższa im. Papieża Jana Pawła II w Białej Podlaskiej, 2018-05-22)
Wróblewska-Łuczka, Paula; Florek-Łuszczki, Magdalena; Łuszczki, Jarogniew J.
At present, there is a great emphasis of public opinion on the legalisation of medical marijuana,
i.e. the top parts of the cannabis plants rich in tetrahydrocannabinol (THC). Nevertheless,
in the cannabis plants, there are many various cannabinoids, including cannabidiol (CBD).
Scientific reports to-date indicate the possibility for using pharmacologically active
cannabinoids in the treatment of such diseases/symptoms as: anorexia, vomiting, neuropathic
pain, inflammatory diseases, multiple sclerosis, degenerative diseases of the central
nervous system (Parkinson’s disease, Huntington’s disease, Alzheimer’s disease, Tourette’s
syndrome), epilepsy, schizophrenia, and obesity. The article presents up-to-date information
on the results of experimental studies concerning the effectiveness of cannabinoids, with
particular consideration of diseases related with the central nervous system, including
epilepsy, neuropathic pain, mental disorders, as well as obesity and anorexia.